Patent · US Active

Method for treating ocular cancer

US8470785B2 · kind B2 · utility

1Cited by

2References

4Claims

0Family size

Assignees

St. Jude Children's Research Hospital, Inc. · US
LEIDEN UNIVERSITY MEDICAL CENTER · NL
VIB VZW and Universiteit Gent · BE

Inventors

Michael Dyer · Memphis, US
Jean-Christophe Marine · Brussels, BE
Aart Gerrit Jochemsen · Leiden, NL
R. Kip Guy · Lexington, US
Fangyi Zhu · Memphis, US

Key dates

Filing date	Sep 27, 2011
Grant date	Jun 25, 2013
Priority date	—
Expiry date	Dec 9, 2031

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P35/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Compositions and methods for treating ocular cancer are provided. The composition is a subconjunctival formulation of nutlin-3 and its analogs. The composition provides for methods of treating ocular cancer, including retinoblastoma. The formulation has high penetration into ocular tissue with low toxicity.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.